Martin L Flanagan
CIK 1010267 · View on SEC EDGAR ↗
First SEC filing: Dec. 17, 2004 · Latest: Dec. 17, 2004
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 1, 2023 | IVZ | S | 232,413 | $17.43 | $4,050,959 | 452,584 Direct | -33.93% | Disposed | 84.1% (price as of 2026-08-20) |
| March 1, 2022 | IVZ | S | 189,708 | $19.51 | $3,701,203 | 487,825 Direct | -28.00% | Disposed | 64.5% (price as of 2026-08-20) |
| Sept. 2, 2020 | IVZ | P | 4,207 | $10.24 | $43,080 | 519,507 Indirect | +0.82% | Acquired | 213.4% (price as of 2026-08-20) |
| Sept. 1, 2020 | IVZ | P | 290,300 | $10.19 | $2,958,157 | 515,300 Indirect | +129.02% | Acquired | 214.9% (price as of 2026-08-20) |
| March 15, 2018 | IVZ | S 10b5-1 | 299,376 | $32.92 | $9,855,458 | 2,074,071 Indirect | -12.61% | Disposed | -2.5% (price as of 2026-08-20) |
| March 14, 2018 | IVZ | S 10b5-1 | 123,484 | $33.62 | $4,151,532 | 2,373,447 Indirect | -4.95% | Disposed | -4.6% (price as of 2026-08-20) |
| March 1, 2016 | IVZ | S | 296,359 | $27.34 | $8,102,455 | 1,960,697 Indirect | -13.13% | Disposed | 17.4% (price as of 2026-08-20) |
| March 2, 2015 | IVZ | S | 161,500 | $40.39 | $6,522,985 | 494,652 Direct | -24.61% | Disposed | -20.5% (price as of 2026-08-20) |
Showing latest 100 of 163 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 12, 2003 | BEN | Employee Stock Option (Right to Buy) | Common Stock, par value $.10 (45,000) | $48.98 | Nov. 11, 2013 | 45,000 | Acquired |
| Oct. 30, 2003 | BEN | Employee Stock Option (Right to Buy) | Common Stock, par value $.10 (82,800) | $33.25 | Dec. 31, 2003 | 82,800 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 14 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 8, 2014 | VLT | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VVR | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VKQ | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VGM | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VMO | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VCV | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VPV | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VTN | Common Shares | 0 | Direct |
| Sept. 8, 2014 | VBF | Common Shares | 0 | Direct |
| June 4, 2010 | IQI | Common Shares | 0 | Direct |
| June 4, 2010 | OIA | Common Shares | 0 | Direct |
| June 4, 2010 | IIM | Common Shares | 0 | Direct |
| July 30, 2007 | IVZ | Ordinary Shares par value $0.10 per share | 1,131,850 | Direct |
| July 30, 2007 | IVZ | Ordinary Shares par value $0.10 per share [F1] | 1,875,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $790,000 | — | — | — | $4,800,000 | — | $90,754 | $12,897,752 |
| 2020 | $790,000 | — | — | — | $3,093,000 | — | $108,118 | $11,747,102 |
| 2014 | $790,000 | — | — | — | $4,925,000 | — | $172,045 | $15,622,002 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.